Zecotek Provides Update on Patent Lawsuit Against Saint-Gobain Corporation and
SINGAPORE, July 10, 2013 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS;
Frankfurt: W1I), a developer of leading-edge photonics technologies for
medical, industrial and scientific markets, today provided an update regarding
the legal action, filed in the United States District Court of Ohio in
February 2012, against defendants Saint-Gobain Corporation and Philips for
infringement of Zecotek's U.S. Patent Number 7,132,060. On July 1 and 2,
2013, a technical tutorial and a claim construction (Markman) hearing were
completed before the Court. In the hearing, the Court considered the meaning
of certain technical terminology used in the patent claim. The date of the
Court's decision following the Markman hearing was not specified.
U.S. Patent No. 7,132,060 was granted to Zecotek on November 6, 2006, is part
of Zecotek's portfolio of over 50 patented and patent pending novel photonic
technologies. The patent covers the substances and chemical formulations
used to grow lutetium fine silicate (LFS) scintillation crystals which are
characterized by their combined high light yield and ultra-fast decay times
and are typically used in medical scanning devices. The lawsuit alleges that
Saint-Gobain's LYSO crystals infringe Zecotek's patent, and that Philips
infringes by using those crystals in the PET scanners it sells.
Zecotek is joined by its exclusive licensee for certain LFS crystals, Beijing
Opto-Electronics Technology Co. Ltd., as co-plaintiff. Zecotek is
represented by Thomas Loop of Loop Intellectual Property Law and Justin Nelson
of Susman Godfrey LLP. Both firms are recognized leaders in patent law and
intellectual property litigation matters.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology
company developing high-performance scintillation crystals, photo detectors,
positron emission tomography scanning technologies, 3D auto-stereoscopic
displays, and lasers for applications in medical, high-tech and industrial
sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems,
Laser Systems and 3D Display Systems with labs located in Canada, Korea,
Russia, Singapore and U.S.A. The management team is focused on building
shareholder value by commercializing over 50 patented and patent pending novel
photonic technologies directly and through strategic alliances and joint
ventures with leading industry partners such as the European Organization for
Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd.
(China), NuCare Medical Systems (South Korea), and National NanoFab Center
(South Korea). For more information visit www.zecotek.com, follow @zecotek
on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on
management's expectations, estimates, projections and assumptions. These
statements are not guarantees of future performance and involve certain risks
and uncertainties, which are difficult to predict. Therefore, actual future
results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of the content of this news
release. If you would like to receive news from Zecotek in the future please
visit the corporate website at www.zecotek.com.
Zecotek Photonics Inc. Michael Minder T: (604) 783-8291 firstname.lastname@example.org
SOURCE: Zecotek Photonics Inc.
To view this news release in HTML formatting, please use the following URL:
CO: Zecotek Photonics Inc.
NI: MTC LAW VERDICTS LAWVIEWS
-0- Jul/10/2013 08:00 GMT
Press spacebar to pause and continue. Press esc to stop.